文献速递泌尿生殖腹部介入MR

经皮MRI引导下实性肾肿块活检的诊断准确性与安全性:4.5年单中心结果

Diagnostic accuracy and safety of percutaneous MRI-guided biopsy of solid renal masses: single-center results after 4.5 years.
PubMed 文献 · Eur Radiol · 2020-08-27

回顾性分析2014年4月至2018年10月共101例经MRI引导下实性肾肿块活检的患者,中位肿瘤大小2.4 cm,诊断准确率97%(95%CI 90-99%),并发症发生率7%(95%CI 1-10%),无变量与诊断样本、诊断准确率或并发症相关。作者认为该技术对超声和CT显示不清、位置难以到达的肿瘤以及年轻或肾功能衰竭患者可能有帮助。

要点

  • MRI引导下实性肾肿块活检诊断准确率97%(95%CI 90-99%),并发症率仅7%(95%CI 1-10%)。
  • 初次诊断率85%(95%CI 77-91%),重复活检后二次诊断率91%(95%CI 84-96%)。
  • 无变量与诊断样本、诊断准确率或并发症相关;作者认为对超声/CT显示不清或难以到达的肿瘤可能有帮助。

核心结论

  • MRI引导下实性肾肿块活检诊断准确率高、并发症率低,该技术对难以到达的肿瘤可能有帮助。

研究设计与样本

  • 回顾性研究,纳入2014年4月至2018年10月连续101例(男69例,女32例;中位年龄68岁,范围32-76岁)经MRI引导下实性肾肿块活检的患者。
  • 使用自由呼吸T2-BLADE和BEAT-IRTTT序列进行MRI引导活检。
  • 诊断准确率按意向诊断基础计算,并评估诊断率;对p<.20的变量进行多变量分析,包括患者年龄/性别、肾肿块大小/位置/与血管蒂接触、RENAL评分、活检样本数量和总长度以及活检道栓塞,以确定与诊断样本、诊断准确率和并发症相关的因素。

关键影像表现/征象

  • 中位肾肿块大小为2.4 cm(范围1-8.4 cm)。

诊断标准与关键数值

  • 诊断样本86例(85%;95%CI 77-91%),非诊断样本15例(15%;95%CI 9-23%)。
  • 15例非诊断活检中6例(40%)重复活检,恶性率为50%。
  • 敏感度96%(95%CI 89-99%),特异度100%(95%CI 77-100%),阳性预测值100%(95%CI 95-100%),阴性预测值82%(95%CI 57-96%),诊断准确率97%(95%CI 90-99%)。
  • 初次诊断率85%(95%CI 77-91%),二次诊断率91%(95%CI 84-96%)。
  • 并发症7例(7%;95%CI 1-10%)。

临床应用与阅片要点

  • 作者认为MRI引导下活检可能特别适用于超声和CT显示不清的肾肿块、相对难以到达的肿瘤(如需要双斜陡角进针的肿瘤)以及年轻患者或肾功能衰竭患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To retrospectively evaluate diagnostic accuracy and complications of magnetic resonance imaging (MRI)-guided biopsy of radiologically indeterminate solid renal masses (RM).

METHODS: Electronic records of all consecutive patients undergoing MRI-guided biopsy of solid RM (using free-breathing T2-BLADE and BEAT-IRTTT sequences) between April 2014 and October 2018 were reviewed; 101 patients (69 men, 32 women; median age 68 years; range 32-76) were included. Patient and RM characteristics, procedural details/complications, pathologic diagnosis, and clinical management were recorded. Diagnostic accuracy was calculated on an intention-to-diagnose basis. Diagnostic yield was also evaluated. Multi-variable analysis was performed for variables with p < .20, including patient age/sex; RM size/location/contact with vascular pedicle, RENAL score, number and total length of biopsy samples, and biopsy tract embolization, to determine factors associated with diagnostic samples, diagnostic accuracy, and complications.

RESULTS: Median RM size was 2.4 cm (range 1-8.4 cm). There were 86 (85%; 95%CI 77-91%) diagnostic and 15 (15%; 95%CI 9-23%) non-diagnostic samples; 6/15 (40%) non-diagnostic biopsies were repeated with 50% malignancy rate. Sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy were 96% (95%CI 89-99%), 100% (95%CI 77-100%), 100% (95%CI 95-100%), 82% (95%CI 57-96%), and 97% (95%CI 90-99%), respectively. Primary and secondary diagnostic yields were 85% (95%CI 77-91%) and 91% (95%CI 84-96%), respectively. Seven (7%; 95%CI 1-10%) complications were observed. No tested variables were associated with diagnostic samples, diagnostic accuracy, or complications.

CONCLUSIONS: MRI-guided biopsy of solid RM is associated with high diagnostic accuracy and low complication rate. The technique might be helpful for inaccessible tumors.

KEY POINTS: • MRI-guided biopsy of radiologically indeterminate solid renal masses (RM) appears safe, with a low rate of minor self-limiting hemorrhagic complications. • Diagnostic accuracy and primary/secondary diagnostic yield are high and appear similar to reported estimates for US- and CT-guided RM biopsy. • MRI guidance may be particularly useful for RM with poor conspicuity on US and CT, for relatively inaccessible tumors (e.g., tumors requiring double-oblique steep-angled approaches), and for young patients or those with renal failure.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Cazzato RL, De Marini P, Auloge P, et al. Diagnostic accuracy and safety of percutaneous MRI-guided biopsy of solid renal masses: single-center results after 4.5 years. Eur Radiol. 2020. PMID: 32851448. doi:10.1007/s00330-020-07160-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。